These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9222049)

  • 1. The pharmacokinetics of teicoplanin in infants and children.
    Reed MD; Yamashita TS; Myers CM; Blumer JL
    J Antimicrob Chemother; 1997 Jun; 39(6):789-96. PubMed ID: 9222049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teicoplanin pharmacokinetics in critically ill paediatric patients.
    Sánchez A; López-Herce J; Cueto E; Carrillo A; Moral R
    J Antimicrob Chemother; 1999 Sep; 44(3):407-9. PubMed ID: 10511412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy.
    Byrne CJ; Roberts JA; McWhinney B; Ryder SA; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; D'Arcy DM; McHugh J
    Clin Microbiol Infect; 2017 Sep; 23(9):674.e7-674.e13. PubMed ID: 28267636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and tonsillar tissue pharmacokinetics of teicoplanin following intramuscular administration to children.
    Aarons L; Rowland M; Khan A; Taborelli G; Ferrea G; Tarantino V; Fioredda F; Rosina-Parenti R; Cavenaghi L; Borgonovi M
    Eur J Pharm Sci; 1998 Oct; 6(4):265-70. PubMed ID: 9795079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of teicoplanin in patients undergoing chronic haemodialysis.
    Papaioannou MG; Marinaki S; Pappas M; Stamatiadis D; Giamarellos-Bourboulis EJ; Giamarellou H; Stathakis C
    Int J Antimicrob Agents; 2002 Mar; 19(3):233-6. PubMed ID: 11932147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers.
    Thompson GA; Smithers JA; Kenny MT; Dulworth JK; Kulmala HK; Yuh L; Lewis EW; Antony KK
    Biopharm Drug Dispos; 1992 Apr; 13(3):213-20. PubMed ID: 1533542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic monitoring of teicoplanin in a severely burned patient].
    Lesne-Hulin A; Bourget P; Le Bever H; Ainaud P; Carsin H
    Ann Fr Anesth Reanim; 1997; 16(4):374-7. PubMed ID: 9750583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of teicoplanin in children.
    Ramos-Martín V; Paulus S; Siner S; Scott E; Padmore K; Newland P; Drew RJ; Felton TW; Docobo-Pérez F; Pizer B; Pea F; Peak M; Turner MA; Beresford MW; Hope WW
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6920-7. PubMed ID: 25224001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors.
    Barbot A; Venisse N; Rayeh F; Bouquet S; Debaene B; Mimoz O
    Intensive Care Med; 2003 Sep; 29(9):1528-34. PubMed ID: 12856119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.
    Zhao W; Zhang D; Storme T; Baruchel A; Declèves X; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2015 Nov; 80(5):1197-207. PubMed ID: 26138279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Teicoplanin Trough Values After the Recommended Loading Dose in Children With Associated Safety Analysis.
    Yamada T; Kubota T; Yonezawa M; Nishio H; Kanno S; Yano T; Kobayashi D; Egashira N; Takada H; Hara T; Masuda S
    Pediatr Infect Dis J; 2017 Apr; 36(4):398-400. PubMed ID: 27977550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age- and gender-related differences in teicoplanin levels in paediatric patients.
    Strenger V; Hofer N; Rödl S; Hönigl M; Raggam R; Seidel MG; Dornbusch HJ; Sperl D; Lackner H; Schwinger W; Sovinz P; Benesch M; Urlesberger B; Urban C
    J Antimicrob Chemother; 2013 Oct; 68(10):2318-23. PubMed ID: 23702837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 14C-teicoplanin in healthy volunteers.
    Buniva G; Del Favero A; Bernareggi A; Patoia L; Palumbo R
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():23-8. PubMed ID: 2965128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teicoplanin pharmacokinetics in pediatric patients.
    Dufort G; Ventura C; Olivé T; Ortega JJ
    Pediatr Infect Dis J; 1996 Jun; 15(6):494-8. PubMed ID: 8783345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers.
    Smithers JA; Kulmala HK; Thompson GA; Antony KK; Lewis EW; Ruberg SJ; Kenny MT; Dulworth JK; Brackman MA
    Antimicrob Agents Chemother; 1992 Jan; 36(1):115-20. PubMed ID: 1534211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a single dose of teicoplanin in burn patients.
    Steer JA; Papini RP; Wilson AP; Dhillon S; Hichens MF; McGrouther DA; Frame JD; Parkhouse N
    J Antimicrob Chemother; 1996 Mar; 37(3):545-53. PubMed ID: 9182111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of teicoplanin in children.
    Tarral E; Jehl F; Tarral A; Simeoni U; Monteil H; Willard D; Geisert J
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():47-51. PubMed ID: 2965131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis.
    Brink AJ; Richards GA; Cummins RR; Lambson J;
    Int J Antimicrob Agents; 2008 Nov; 32(5):455-8. PubMed ID: 18718742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loading dose required to achieve rapid therapeutic teicoplanin trough plasma concentration in patients with multidrug-resistant gram-positive infections.
    Wang JT; Liao HI; Wu Lin FL; Chang SC
    Basic Clin Pharmacol Toxicol; 2012 May; 110(5):416-20. PubMed ID: 22309355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.